Biomerica, Inc.
BMRA
$2.71
-$0.08-2.87%
NASDAQ
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 100.15% | -8.66% | 39.36% | 36.96% | -16.25% |
| Total Depreciation and Amortization | 5.15% | 7.22% | 5.32% | 9.89% | 5.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.36% | -10.23% | -78.51% | 82.72% | 213.33% |
| Change in Net Operating Assets | -151.14% | 497.12% | 83.01% | -118.05% | 67.02% |
| Cash from Operations | 80.06% | 36.69% | 41.98% | 6.06% | 19.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 75.00% | -450.00% | -- |
| Cash from Investing | -- | 100.00% | 75.00% | -175.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 95.06% | -- | -- | -- |
| Cash from Financing | -- | 93.83% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 133.33% | -- | -150.00% | -- | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 148.44% | 42.73% | 137.80% | 47.54% | 22.01% |